Cancer Incidence and Mortality among Non-Hispanic Black Individuals, New York County (Manhattan), 2016-2020
Source: New York State Cancer Registry
Site of Cancer | Incidence | Mortality | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Males and Females | Males | Females | Males and Females | Males | Females | |||||||||||||
Average Annual Cases | Rate per 100,000 Population | 95% CI | Average Annual Cases | Rate per 100,000 Males | 95% CI | Average Annual Cases | Rate per 100,000 Females | 95% CI | Average Annual Deaths | Rate per 100,000 Population | 95% CI | Average Annual Deaths | Rate per 100,000 Males | 95% CI | Average Annual Deaths | Rate per 100,000 Females | 95% CI | |
All Invasive Malignant Tumors | 1,302.0 | 500.0 | 487.7-512.5 | 628.0 | 588.4 | 567.4-610.0 | 674.0 | 451.4 | 435.8-467.4 | 467.2 | 176.2 | 169.0-183.6 | 215.2 | 217.5 | 204.4-231.3 | 252.0 | 155.5 | 146.8-164.6 |
Oral cavity and pharynx | 26.6 | 10.2 | 8.5-12.2 | 18.2 | 16.7 | 13.4-20.7 | 8.4 | 5.8 | 4.1-8.0 | 7.6 | 2.9 | 2.0-4.0 | 4.2 | 4.2 | 2.6-6.5 | 3.4 | 2.1 | 1.2-3.5 |
Esophagus | 10.0 | 3.7 | 2.7-4.9 | 5.2 | 4.8 | 3.1-7.1 | 4.8 | 3.1 | 2.0-4.7 | 7.8 | 2.9 | 2.1-4.0 | 3.8 | 3.8 | 2.2-6.0 | 4.0 | 2.5 | 1.5-3.9 |
Stomach | 23.4 | 9.1 | 7.5-11.0 | 12.6 | 12.2 | 9.3-15.8 | 10.8 | 7.0 | 5.2-9.2 | 11.6 | 4.4 | 3.3-5.7 | 6.0 | 5.5 | 3.7-7.9 | 5.6 | 3.3 | 2.2-4.8 |
Colorectal | 105.8 | 41.0 | 37.5-44.7 | 54.0 | 52.5 | 46.3-59.4 | 51.8 | 33.7 | 29.6-38.2 | 45.6 | 17.3 | 15.1-19.8 | 23.4 | 24.2 | 19.9-29.1 | 22.2 | 13.0 | 10.7-15.8 |
Colon excluding rectum | 76.6 | 29.5 | 26.6-32.7 | 37.6 | 36.8 | 31.6-42.6 | 39.0 | 25.3 | 21.7-29.2 | 34.0 | 13.0 | 11.1-15.2 | 16.0 | 16.8 | 13.2-21.0 | 18.0 | 10.6 | 8.5-13.2 |
Rectum & rectosigmoid | 29.2 | 11.5 | 9.7-13.6 | 16.4 | 15.8 | 12.5-19.7 | 12.8 | 8.4 | 6.4-10.9 | 11.6 | 4.3 | 3.3-5.7 | 7.4 | 7.4 | 5.1-10.3 | 4.2 | 2.4 | 1.5-3.8 |
Liver / intrahepatic bile duct | 45.0 | 16.4 | 14.3-18.7 | 31.2 | 28.2 | 23.8-33.2 | 13.8 | 8.5 | 6.6-10.8 | 26.0 | 9.7 | 8.1-11.6 | 16.6 | 16.3 | 12.9-20.4 | 9.4 | 5.8 | 4.2-7.8 |
Pancreas | 47.6 | 17.7 | 15.5-20.2 | 22.4 | 21.9 | 17.9-26.5 | 25.2 | 15.3 | 12.7-18.4 | 39.0 | 14.4 | 12.4-16.6 | 17.0 | 16.8 | 13.3-20.9 | 22.0 | 13.1 | 10.7-15.9 |
Larynx | 10.0 | 3.6 | 2.7-4.8 | 7.6 | 7.0 | 4.9-9.8 | 2.4 | 1.5 | 0.8-2.7 | 4.0 | 1.4 | 0.8-2.2 | 2.8 | 2.5 | 1.4-4.3 | 1.2 | 0.7 | 0.2-1.6 |
Lung and bronchus | 155.8 | 58.3 | 54.3-62.6 | 72.8 | 69.7 | 62.6-77.5 | 83.0 | 51.3 | 46.4-56.7 | 90.6 | 33.6 | 30.6-36.9 | 45.0 | 44.5 | 38.8-50.9 | 45.6 | 27.5 | 24.0-31.5 |
Melanoma of the skin | 4.0 | 1.5 | 0.9-2.3 | 1.4 | 1.2 | 0.5-2.6 | 2.6 | 1.7 | 0.9-3.1 | 0.8 | 0.3 | 0.1-0.8 | 0.2 | 0.2 | 0.0-1.1 | 0.6 | 0.3 | 0.1-1.2 |
Female breast | 196.6 | 137.9 | 129.1-147.1 | 44.4 | 28.5 | 24.7-32.7 | ||||||||||||
Cervix uteri | 15.4 | 11.3 | 8.8-14.2 | 6.0 | 4.0 | 2.7-5.9 | ||||||||||||
Corpus uterus and NOS | 59.8 | 38.4 | 34.1-43.2 | 16.0 | 9.8 | 7.8-12.3 | ||||||||||||
Ovary | 14.2 | 9.9 | 7.6-12.6 | 10.0 | 6.2 | 4.6-8.2 | ||||||||||||
Prostate | 218.2 | 196.1 | 184.3-208.4 | 36.6 | 39.4 | 33.8-45.7 | ||||||||||||
Testis | 4.0 | 3.6 | 2.2-5.7 | 0.2 | 0.2 | 0.0-1.3 | ||||||||||||
Urinary bladder (incl. in situ) | 35.2 | 13.5 | 11.6-15.7 | 22.0 | 22.6 | 18.5-27.4 | 13.2 | 8.3 | 6.4-10.7 | 10.8 | 4.0 | 3.0-5.3 | 6.4 | 7.1 | 4.8-10.0 | 4.4 | 2.4 | 1.5-3.8 |
Kidney and renal pelvis | 47.6 | 18.2 | 15.9-20.8 | 28.4 | 25.4 | 21.3-30.1 | 19.2 | 12.9 | 10.3-15.8 | 7.0 | 2.7 | 1.9-3.8 | 2.6 | 2.6 | 1.4-4.5 | 4.4 | 2.7 | 1.7-4.3 |
Brain and other central nervous system | 10.4 | 4.3 | 3.2-5.7 | 4.6 | 4.4 | 2.8-6.8 | 5.8 | 4.2 | 2.7-6.2 | 7.2 | 2.8 | 1.9-3.9 | 4.4 | 4.0 | 2.5-6.2 | 2.8 | 1.8 | 1.0-3.2 |
Thyroid | 25.4 | 10.6 | 8.8-12.6 | 4.8 | 4.1 | 2.6-6.2 | 20.6 | 16.3 | 13.2-20.0 | 0.6 | 0.3 | 0.0-0.8 | 0.4 | 0.5 | 0.1-1.7 | 0.2 | 0.1 | 0.0-0.9 |
Hodgkin lymphoma | 9.2 | 3.9 | 2.8-5.2 | 5.0 | 5.0 | 3.2-7.5 | 4.2 | 3.1 | 1.9-4.9 | 0.2 | 0.1 | 0.0-0.5 | 0.2 | 0.2 | 0.0-1.1 | 0.0 | 0.0 | 0.0-0.7 |
Non-Hodgkin lymphomas | 48.2 | 19.4 | 17.0-22.1 | 25.2 | 24.5 | 20.3-29.3 | 23.0 | 15.8 | 13.0-19.2 | 11.0 | 4.4 | 3.3-5.8 | 6.2 | 6.6 | 4.4-9.4 | 4.8 | 3.0 | 1.9-4.5 |
Myeloma | 37.0 | 14.3 | 12.3-16.6 | 17.0 | 16.4 | 13.0-20.5 | 20.0 | 12.8 | 10.3-15.7 | 11.4 | 4.3 | 3.2-5.6 | 4.4 | 4.4 | 2.7-6.8 | 7.0 | 4.3 | 3.0-6.1 |
Leukemias | 26.4 | 10.7 | 8.9-12.8 | 13.0 | 12.9 | 9.9-16.6 | 13.4 | 9.2 | 7.0-11.9 | 13.4 | 5.3 | 4.1-6.8 | 5.8 | 6.1 | 4.1-8.9 | 7.6 | 5.0 | 3.5-7.1 |
Notes
- Incidence data are provisional, November 2022.
- Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
- Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
- NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.